Avulux spectacle lenses are designed to decrease migraines by addressing light sensitivity, a common trigger for migraine sufferers.

These lenses use a patented nanomolecular multi-band precision filter technology to selectively block specific wavelengths of light—up to 97% of high energy blue, amber, and red light—known to exacerbate migraine symptoms.

Research, including a 2020 double-blind, randomized, placebo-controlled study (1) , has shown that these wavelengths can overexcite melanopsin-secreting retinal cells, leading to increased migraine pain. By filtering these harmful lights while allowing over 70% of soothing green light to pass through, Avulux lenses reduce eye strain and the likelihood of migraine attacks.

Unlike traditional FL-41 lenses, which only filter a narrow band of light and are cosmetically intrusive to look at, Avulux lenses are color-neutral, avoiding distortion and making them suitable for all-day wear, indoors or outdoors.

Clinical trials and user reports indicate that 90% of wearers experience relief, enabling them to resume daily activities without retreating to a dark room. Developed over eight years with input from neuro-ophthalmologists and optical engineers, Avulux lenses offer a non-invasive, drug-free option to manage migraine-related photophobia effectively.

At Advanced Optometry, we understand the impact migraines can have for patients. We stock multiple Avalux lens test kits and can loan patients a test set of Avalux lenses to wear for 1-2 weeks to help you decide on whether these lenses may be beneficial for you.

(1) Targeting the intrinsically photosensitive retinal ganglion cell to reduce headache pain and light sensitivity in migraine: A randomized double-blind trial. Posternack, Charles et al. Journal of Clinical Neuroscience, Volume 113, 22 - 31. https://www.jocn-journal.com/article/S0967-5868(23)00095-4/abstract

(2) Hoggan RN, Subhash A, Blair S, Digre KB, Baggaley SK, Gordon J, Brennan KC, Warner JE, Crum AV, Katz BJ. Thin-film optical notch filter spectacle coatings for the treatment of migraine and photophobia. J Clin Neurosci. 2016 Jun;28:71-6. doi: 10.1016/j.jocn.2015.09.024. Epub 2016 Feb 28. PMID: 26935748; PMCID: PMC5510464. https://pmc.ncbi.nlm.nih.gov/articles/PMC5510464/